🔎 Trials Near Me

Home › Heart Failure › Washington

Heart Failure clinical trials in Washington

25 studies for Heart Failure are looking for participants at sites in Washington.

Cities in Washington

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
RecruitingPhase 2/3
29 Days – 17 Years · All sexes · Updated Nov 13, 2026 · NCT05714085

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  • Virginia Mason Medical Center, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06424288

Left vs Left Randomized Clinical Trial

  • University of Washington, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT05650658

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Olympia
RecruitingObservational study
All ages · All sexes · Updated Nov 4, 2026 · NCT00271180

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Providence Advanced Heart Disease and Transplant, Spokane
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT06736574

ELEVATE-HFpEF Clinical Study

  • Saint Joseph Medical Center (Tacoma WA), Tacoma
Recruiting
Ages 40 and older · All sexes · Updated Nov 3, 2026 · NCT06678841

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Pulse Heart Institute, Puyallup
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 29, 2026 · NCT07037459

CCM OPEN HF Registry

  • PeaceHealth Southwest Medical Center, Vancouver
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07112924

Cardiogenic Shock Working Group Registry

  • University of Washington Medical Center, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT04682483

Assessment of CCM in HF With Higher Ejection Fraction

  • Swedish Medical Center, Seattle
  • Peace Health, Vancouver
Recruiting
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT05064709

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Puyallup
  • Research Site, Redmond
  • Research Site, Renton
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Oct 21, 2026 · NCT06677060

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

  • Local Institution - 23, Seattle
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Oct 13, 2026 · NCT07795814

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Redmond
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Spokane, WA Investigative Site 10123, Spokane
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 27, 2026 · NCT06793371

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Swedish Medical Center_Seattle, Seattle
  • CHI Franciscan Research Center, Tacoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

  • Seattle Children's Hospital, Seattle
RecruitingPhase 2
Ages 0 to 16 · All sexes · Updated Aug 10, 2026 · NCT06080074

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • Providence Everett, Everett
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487

Repurposing Valsartan May Protect Against Pulmonary Hypertension

  • University of Washington Medical Center, Seattle
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated May 4, 2026 · NCT06053580

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • University of Washington, Seattle
  • Providence Sacred Heart Medical Center, Spokane
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06217302

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

  • University of Washington Medical Center, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT06895070

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV

  • University of Washington, Seattle
Recruiting
Ages 40 and older · All sexes · Updated Mar 16, 2026 · NCT07105007

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

  • University of Washington Medicine, Seattle
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Mar 26, 2024 · NCT04703842

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

  • University of Washington Medical Center, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Feb 23, 2021 · NCT02537769

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.